相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia
Christina Egnell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment
Joanna S. Yi et al.
HAEMATOLOGICA (2022)
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
David T. Teachey et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
Cecilie U. Rank et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia
Saman K. Hashmi et al.
PEDIATRIC BLOOD & CANCER (2020)
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Sumit Gupta et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer Progress and Priorities: Childhood Cancer
Philip J. Lupo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131
Wanda L. Salzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Kimberly P. Dunsmore et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia
M. K. Mateos et al.
THROMBOSIS RESEARCH (2019)
The Children's Oncology Group: Organizational Structure, Membership, and Institutional Characteristics
Janice S. Withycombe et al.
JOURNAL OF PEDIATRIC ONCOLOGY NURSING (2019)
Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis
Irene L. M. Klaassen et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia
N. Toft et al.
LEUKEMIA (2018)
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
Cecilie Utke Rank et al.
BLOOD (2018)
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization
Stuart S. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy
Y. Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
Nobuko Hijiya et al.
LEUKEMIA & LYMPHOMA (2016)
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232
Eric C. Larsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E. Place et al.
LANCET ONCOLOGY (2015)
Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines
Jean Hugues Parmentier et al.
LEUKEMIA RESEARCH (2015)
PEG-Asparaginase Allergy in Children With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Protocol
Louise Tram Henriksen et al.
PEDIATRIC BLOOD & CANCER (2015)
Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia
Ching-Hon Pui
FRONTIERS OF MEDICINE (2015)
Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Etan Orgel et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
K. R. Schultz et al.
LEUKEMIA (2014)
Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031
K. R. Schultz et al.
LEUKEMIA (2014)
Increased Pancreatic Fat Fraction Is Present in Obese Adolescents With Metabolic Syndrome
Albane B. R. Maggio et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Delivery of Therapeutic Proteins
Dipak S. Pisal et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Erwinia Asparaginase After Allergy to E. coli Asparaginase in Children With Acute Lymphoblastic Leukemia
Lynda M. Vrooman et al.
PEDIATRIC BLOOD & CANCER (2010)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Obesity-Associated Liver Disease
Giulio Marchesini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Body mass index measurement in schools
Allison J. Nihiser et al.
JOURNAL OF SCHOOL HEALTH (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
分享论文
